Citing “Incomplete Technologies,” Atul Gawande Calls For Increased Automation
This article was originally published in The Gray Sheet
Executive Summary
Harvard surgeon Atul Gawande argues that most health care innovations are still “incomplete.” Automation based on data is needed, he says.
You may also be interested in...
Accenture Prescribes A New Data Management Future For Medtechs
The value of revenue streams derived from new business models is increasingly defined by how well companies manage the data within their ecosystems. Managing the data in the "last mile" subset provides an opportunity for medtech companies to generate income in that revenue stream, says Maximilian Schmid, head of the Global MedTech Practice at Accenture Life Sciences.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.